Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Omya International
Omya International
Activities:
Distribution
Ingredients
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Omya set to unveil pharmaceutical solutions at CPhI in Barcelona
Swiss mineral expert Omya is set to attend CPhI with the Omyanutra range, offering advanced excipients to help produce stable and fast disintegrating oral tablets (ODTs) and powders
Distribution
Omya and Harke announce distribution partnership
Targeting pharmaceutical and nutraceutical markets, Omya provides its exclusive mineral ingredients with advanced functionalities that ease into HARKE's pharma & nutra portfolio
Finance
DKSH enters European distribution agreement with Omya
The distributor was reportedly chosen for its expansive network and strong service capabilities
Ingredients
Omya completes expansion of Orgon production plant
State-of-the-art facility for sustainable, high-quality mineral products
Ingredients
Omya launches new Calcipur DC range
Calcipur DC can be used as an active ingredient in nutraceuticals and as a diluent in pharmaceuticals
Regulatory
Omya site in France gains excipient GMP certification
Manufacturing
A perfect match for tablets
The multifunctional mineral excipient Omyapharm provides oral dosage forms with excellent processing properties
Subscribe now